This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2009 by Office of Rare Diseases (ORD).
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
FDA Office of Orphan Products Development
Information provided by:
Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:
NCT00414648
First received: December 20, 2006
Last updated: August 27, 2009
Last verified: August 2009